A 24-year-old female with pemphigus vulgaris developed atypical Hand, Foot, and Mouth Disease following rituximab treatment, highlighting the risk of opportunistic viral infections.
Case Report (n=1)
No
Rituximab treatment for pemphigus vulgaris can be complicated by atypical presentations of Hand, Foot, and Mouth Disease, highlighting the need for vigilant infection surveillance.
Vaidh et al. (Fri,) conducted a case report in Pemphigus vulgaris (n=1). Rituximab was evaluated. A 24-year-old female with pemphigus vulgaris developed atypical Hand, Foot, and Mouth Disease following rituximab treatment, highlighting the risk of opportunistic viral infections.